SCHEMBL7787470

SCHEMBL7787470

CC[C@@H](NC(c1ccc(F)cc1)c1cccc([N+](=O)[O-])c1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.43
AKR1C2 P52895 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 4/20 0.42
ACP3 P15309 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 2/20 0.40
SLC6A9 P48067 1/20 0.40
HPGD P15428 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP3A4 P08684 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27553469 1.00 AKR1C3 (0.43) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7780324 0.85 CRHBP (0.47) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL27533527 0.80 MEN1 (0.40) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7780359 0.80 MAPT (0.41) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7787532 0.80 MEN1 (0.40) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7780398 0.79 TDP1 (0.46) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7780395 0.79 MEN1 (0.42) ALDH1A1MEN1KMT2ASLC6A9SLC6A2
SCHEMBL7785688 0.78 CRHBP (0.44) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7785576 0.78 CRHBP (0.44) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2
SCHEMBL7785105 0.78 CRHBP (0.44) AKR1C3AKR1C2L3MBTL1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329405-B1 AS ILEAL BILE ACID TRANSPORTER INHIBITOR, FOR THERAPY OF HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 2001-12-11 US disclosed
CN-1287117-A Cyclobutene derivatives, preparation method and therapeutic use thereof SANKYO CO (JP) 2001-03-14 CN disclosed
EP-1070703-A1 Cyclobutene derivatives Sankyo Company Limited (JP) 2001-01-24 EP disclosed